1. Home
  2. AMWL vs MXCT Comparison

AMWL vs MXCT Comparison

Compare AMWL & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$5.55

Market Cap

94.8M

Sector

Technology

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.72

Market Cap

81.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
MXCT
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.8M
81.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AMWL
MXCT
Price
$5.55
$0.72
Analyst Decision
Hold
Buy
Analyst Count
7
4
Target Price
$7.42
$5.50
AVG Volume (30 Days)
56.2K
982.6K
Earning Date
04-30-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
N/A
EPS
N/A
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
N/A
$18.61
Revenue Next Year
$4.24
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$0.64
52 Week High
$9.15
$2.96

Technical Indicators

Market Signals
Indicator
AMWL
MXCT
Relative Strength Index (RSI) 51.45 38.93
Support Level $4.48 $0.64
Resistance Level $5.81 $0.87
Average True Range (ATR) 0.34 0.06
MACD -0.03 0.00
Stochastic Oscillator 26.90 28.02

Price Performance

Historical Comparison
AMWL
MXCT

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: